Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gut bacteria may help bladder cancer patients keep their bladder

NCT ID NCT07474064

Not yet recruiting Disease control Sponsor: chenxu Source: ClinicalTrials.gov ↗

First seen Mar 16, 2026 · Last updated May 15, 2026 · Updated 9 times

Summary

This study tests whether taking a probiotic (Clostridium butyricum) can improve the effectiveness of a combination of targeted therapy and immunotherapy in people with muscle-invasive bladder cancer who cannot receive standard chemotherapy. The goal is to preserve the bladder and avoid its removal. About 146 participants will receive either the probiotic plus the drug combination or the drug combination alone for one year, and researchers will monitor how long the bladder remains cancer-free.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER (MIBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sun Yat-sen Memorial Hospital

    Guangzhou, Guangdong, 510120, China

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.

MUSCLE INVASIVE BLADDER CANCER (MIBC)